IQ EQ Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
IQ EQ Fund Management's BMY Position: Q2 2026 in Review
IQ EQ Fund Management increased its Bristol-Myers Squibb (BMY) stake by 22% in Q2 2026, buying an estimated $1.46M and bringing the position to 138,710 shares worth $7.99M. The position accounts for 0.51% of the portfolio, ranked #63.
IQ EQ Fund Management first reported a position in BMY in Q4 2014 and has held it in 23 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- IQ EQ Fund Management held 138,710 shares of Bristol-Myers Squibb worth $7.99M as of Q2 2026.
- IQ EQ Fund Management bought 25,400 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.46M.
- Bristol-Myers Squibb made up 0.51% of IQ EQ Fund Management's portfolio in Q2 2026, its #63 holding.
- IQ EQ Fund Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 23 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.